Topic
340B
257 published works
Medicaid & Medicare: A Legal Blog
April Fools’ Day and the Supreme Court: A 340B Comedy of Errors
Happy April Fools’ Day! In a move that shocked absolutely no one (except maybe a few overconfident pharmaceutical executives), the U.S. Supreme Court decided in December 2024 that it would…
Medicaid & Medicare: A Legal Blog
Understanding 340B: A Lifeline for Underserved Communities
The 340B Drug Pricing Program, created by the U.S. federal government in 1992, is a critical healthcare initiative designed to help low-income and underserved communities gain access to affordable medications.…
Nonprofit Law Prof Blog
Arkansas Debates Nonprofit Health Care Subsidies and Unfair Competition
Hospitals, both nonprofit and for profit, participate in what must be a tangled and sometimes indecipherable system of government subsidies, all of which are regulated by statutes and regulations more…
To Be or Not to 340B Blog
The 340B Program in 2024: A Tumultuous Year in Review
By Brenda Maloney Shafer, Richard Davis, Michael French
The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments…
Drug & Device Law
Shameless Plug – Anybody Need End of the Year CLE?
By Bexis
To anyone who needs a few more CLE hours before the end of the 2024, we wanted to let you know that videotaped sessions from last week’s Reed Smith Annual…
Healthcare Law Blog
California Votes to Impose 340B Spending Restrictions on Targeted 340B Providers
By Amanda Bogle
California is poised to pass a ballot measure aimed at imposing 340B spending restrictions for certain healthcare entities participating in the 340B Program who have historically engaged in spending that…
Rivkin Rounds
HRSA to J&J: Cease Implementation of New 340B Rebate Model
As previously discussed here, Johnson & Johnson (J&J) recently announced its intention to change its 340B Drug Pricing Program discount available to disproportionate share hospital (DSH) Covered Entities on purchases…
Rivkin Rounds
J&J Announces New Rebate Model for 340B Program, but HRSA Pushes Back
On August 23, Johnson & Johnson (J&J) announced changes to its 340B Drug Pricing Program discount available to disproportionate share hospital (DSH) Covered Entities on purchases of two of J&J’s…
Take Stock: Federal Policy Watch
Washington Healthcare Update | June 10, 2024
By Stephanie A. Kennan, Gina Sherick, Gabriel Wiedenhoever
This Week in Washington: Senate Finance Committee Chairman sends letters concerning healthcare cybersecurity measures; House Energy and Commerce Committee Oversight and Investigations Subcommittee holds hearing on 340B program; CMS releases 2025…
To Be or Not to 340B Blog
HHS’ Long-Awaited 340B Alternative Dispute Resolution Rule Is Finalized
By Richard Davis, Michael French, Brenda Maloney Shafer
In a move long anticipated by 340B Program participants, the Department of Health and Human Services (HHS) recently published its finalized 340B Administrative Dispute Resolution (ADR) rule, establishing formal processes for resolving certain…